Levamisole en la enfermedad de Crohn.

Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2009

Earlier diagnosis and treatment of symptomatic bowel cancer: can it be achieved and how much will it improve survival?

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2009

Bradykinin regulates human colonic ion transport in vitro.

British journal of pharmacology·2008

Infliximab therapy in Crohn's disease: a pragmatic approach?

Alimentary pharmacology & therapeutics·2006

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

Annals of oncology : official journal of the European Society for Medical Oncology·2006

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Histopathology·2005

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

A Rare Presentation of Acute Cholecystitis Mimicking Malignancy in a Young Male With Elevated IgG4.

Cureus·2026

Identification of <i>Leishmania major</i> and Other Causative Species in Syrian Patients Infected with Cutaneous Leishmaniasis.

Iranian journal of parasitology·2026

A map of intra- and intercellular immune responses across diverse in vitro stimuli and inflammatory disease.

Genome medicine·2026

Photonic waveguide chip-based nanoscopy visualizes rearrangements of the cortical actin cytoskeleton in activated Jurkat T cells.

Science advances·2026

Protocol for deep phenotyping of human antigen-specific T cells across conventional and unconventional subsets by 22-color spectral flow cytometry.

STAR protocols·2026

Rapid and accessible tumor necrosis factor alpha detection using digital nanoparticle sensors towards point-of-care cytokine monitoring.

Sensors and actuators. B, Chemical·2026

Videos de Experimentos Relacionados

Levamisole en la enfermedad de Crohn.

Videos de Conceptos Relacionados

Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre.

Earlier diagnosis and treatment of symptomatic bowel cancer: can it be achieved and how much will it improve survival?

Bradykinin regulates human colonic ion transport in vitro.

Infliximab therapy in Crohn's disease: a pragmatic approach?

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

A Rare Presentation of Acute Cholecystitis Mimicking Malignancy in a Young Male With Elevated IgG4.

Identification of <i>Leishmania major</i> and Other Causative Species in Syrian Patients Infected with Cutaneous Leishmaniasis.

A map of intra- and intercellular immune responses across diverse in vitro stimuli and inflammatory disease.

Photonic waveguide chip-based nanoscopy visualizes rearrangements of the cortical actin cytoskeleton in activated Jurkat T cells.

Protocol for deep phenotyping of human antigen-specific T cells across conventional and unconventional subsets by 22-color spectral flow cytometry.

Rapid and accessible tumor necrosis factor alpha detection using digital nanoparticle sensors towards point-of-care cytokine monitoring.

Videos de Experimentos Relacionados

Levamisole en la enfermedad de Crohn.

Videos de Conceptos Relacionados

Artículos Relacionados